Manufacturing Kicks Off, Q1 Profit Jumps 347% YoY
BALAXI PHARMACEUTICALS LIMITED · BALAXI · NSE ·
**Net Profit After Tax (PAT)** surged 347% year-over-year to ₹129.74 Lakhs for Q1 FY27. **Revenue from Operations** grew 14% YoY to ₹8,068.18 Lakhs. Successfully **commenced commercial production** at its new pharmaceutical manufacturing facility in Jadcherla, Hyderabad. Received…